Compulsory licensing in Canada and Thailand: comparing regimes to ensure legitimate use of the WTO rules
- PMID: 19493068
- DOI: 10.1111/j.1748-720X.2009.00367.x
Compulsory licensing in Canada and Thailand: comparing regimes to ensure legitimate use of the WTO rules
Abstract
This paper examines two recent examples of compulsory licensing legislation: one globally embraced regime and one internationally controversial regime operating under the same WTO rules. In particular, we consider Canadian legislation and the use of compulsory licensing for HIV/AIDS drugs destined for a developing country. This is then contrasted with the conditions under which Thai authorities are pursuing compulsory licenses, the outcomes of their compulsory licenses, as well as the likely impact of the Thai policy. Finally, we construct a rubric to evaluate characteristics of a successful regime. This is used to analyze the Canadian and Thai regimes and frame the expected implications of each national policy. It is hoped that the assessment will guide changes to compulsory licensing design to ensure that legitimate regimes are embraced while illegitimate ones are disallowed.
Similar articles
-
Developing nations and the compulsory license: maximizing access to essential medicines while minimizing investment side effects.J Law Med Ethics. 2009 Summer;37(2):209-21. doi: 10.1111/j.1748-720X.2009.00366.x. J Law Med Ethics. 2009. PMID: 19493067
-
Comment: compulsory licensing of patented pharmaceutical inventions: evaluating the options.J Law Med Ethics. 2009 Summer;37(2):247-63. doi: 10.1111/j.1748-720X.2009.00369.x. J Law Med Ethics. 2009. PMID: 19493070 Free PMC article.
-
An economic justification for open access to essential medicine patents in developing countries.J Law Med Ethics. 2009 Summer;37(2):184-208. doi: 10.1111/j.1748-720X.2009.00365.x. J Law Med Ethics. 2009. PMID: 19493066
-
Sustaining access to antiretroviral therapy in the less-developed world: lessons from Brazil and Thailand.AIDS. 2007 Jul;21 Suppl 4:S21-9. doi: 10.1097/01.aids.0000279703.78685.a6. AIDS. 2007. PMID: 17620749 Review.
-
The case for compulsory licensing during COVID-19.J Glob Health. 2020 Jun;10(1):010358. doi: 10.7189/jogh.10.010358. J Glob Health. 2020. PMID: 32509289 Free PMC article. Review. No abstract available.
Cited by
-
Using TRIPS flexibilities to facilitate access to medicines.Bull World Health Organ. 2013 Jul 1;91(7):533-9. doi: 10.2471/BLT.12.115865. Epub 2013 Apr 18. Bull World Health Organ. 2013. PMID: 23825881 Free PMC article.
-
Health and health-care systems in southeast Asia: diversity and transitions.Lancet. 2011 Jan 29;377(9763):429-37. doi: 10.1016/S0140-6736(10)61507-3. Lancet. 2011. PMID: 21269685 Free PMC article.
-
Compulsory licensing and access to drugs.Eur J Health Econ. 2015 Jan;16(1):83-94. doi: 10.1007/s10198-013-0556-2. Epub 2014 Jan 10. Eur J Health Econ. 2015. PMID: 24408475
-
Between Regional Recommendations and National Implementation: An Analysis of the East African Community Partner States' Legislative Responses to TRIPS Obligations.IIC Int Rev Ind Prop Copyr Law. 2023;54(5):673-709. doi: 10.1007/s40319-023-01318-7. Epub 2023 May 3. IIC Int Rev Ind Prop Copyr Law. 2023. PMID: 37215360 Free PMC article.
-
Scaling up chronic disease prevention interventions in lower- and middle-income countries.Annu Rev Public Health. 2013;34:317-35. doi: 10.1146/annurev-publhealth-031912-114402. Epub 2013 Jan 7. Annu Rev Public Health. 2013. PMID: 23297660 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical